General Assembly Meeting Thursday, May 5th 10:00 – 13:00

General Assembly Meeting - 2022

A virtual (Zoom) and face-to-face meeting in Paris, France

followed by Lunch

Other Logistical information to follow nearer the time




The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.

Manganese ores, reduced (EC: 273-748-0; Cas: 69012-49-3)

Submitted in 2010, with no testing proposals, this substance has not undergone any aspect of the REACH evaluation process to date.

So far, the reveiw of the orginal 2010 dossier  along side post 2010 ECHA guidance documents on substance ID, has led to a slight change on the SIP/Boundary composition. 

New updated 2019 SIP/Boundary composition:

Boundary Composition
Component Silicon Dioxide Aluminium Oxide Barium Oxide Calcium Oxide Iron & Oxides of Iron Manganese and oxides of Manganese    

(% w/w) (Range)

8.5 (5-10)

7.5 (5-10)

0 (0-1)

3 (1-10)

8 (5-15)

50 (45-60)



While this dossier has not undergone any compliance check request from the ECHA , other UVCB substances in thesame readacross category required significant dossier updates and testing request from ECHA. 

In view of the newly generated serrogate data, this dossier has been updated in Q3, 2020. The updated dossier has an updated self classifcation for pre-natal development emanating from the a pre-natal developmental toxicity study on readacross substance FeMn slag.  To this end, a new/updated CSR   and ES has been generated. 

The secretariat therefore encourages all registrants to update their dossiers accordingly. Please request your updated CSR's and ES by contacting

Note: Post 2018, the consortium will no longer invoice co-registrants  for ECHA requested studies retrospectively. All compliance check related work will require co-registrants to contribute their share before any dossier update work can begin. 

« Back to news

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)